Labs / ADME, DMPK & toxicology

Ability Biotherapeutics
Montreal, QC, Canada · ability.bio
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Ability Biotherapeutics develops fully-human therapeutic antibodies using its AbiLeap discovery engine. It is developing antibody candidates for autoimmune and inflammatory diseases, including a lead preclinical immune cell depleter for inflammatory skin diseases.
Their website has a general contact form; we send your quote request through it.
What they offer
AbiLeap discovery engine
Uses massively parallel, continuously learning artificial intelligence and a proprietary database of therapeutic antibody sequences and antigen-antibody interactions to generate fully-human antibodies.
Antibody engineering for selectivity and specificity
Engineers conventional IgGs for properties such as dual specificity, metabolite sensing, or rare epitope binding.
Monospecific antibody candidate development
Develops monospecific antibody candidates with selectivity for specific immune cell subpopulations.
What they work on
- Modalities
- Small molecule, Antibody
- Therapeutic areas
- autoimmune diseases, inflammatory diseases, inflammatory skin diseases
- Address
- 2025 Announcement Dr. Elizabeth Quackenbush appointed Chief Medical Officer Read more Sept
- Founded
- 2010
Similar labs. Aclairo Pharmaceutical Development Group, Inc., ACM Global Laboratories, Allumiqs, AxisPharm
Found in a contract services directory. Listing built from ability.bio. Work here? Claim this listing.